MediciNova, Inc. (MNOV) Social Stream



MediciNova, Inc. (MNOV): $2.41

-0.05 (-2.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MNOV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

MEDICINOVA INC (MNOV) Price Targets From Analysts

Use the tables below to see what analysts covering MEDICINOVA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 3 $27 $10 $16.5 $2.48 565.32%
2022-03-01 3 $27 $6 $14.333 $2.48 477.94%
2022-04-06 1 $27 $6 $14.333 $2.48 477.94%
2022-08-19 2 $27 $6 $13 $2.48 424.19%
2022-12-15 3 $27 $6 $13 $2.48 424.19%

The Trend in the Analyst Price Target


Over the past 31 months, MNOV's average price target has gone down $5.32.

Over the past 47 weeks, MNOV's average upside potential has been 462.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-01 1 27 6 14.333 2.35 509.91%
2022-04-06 1 27 6 14.333 2.80 411.89%
2022-04-06 2 27 6 14.333 2.80 411.89%
2022-04-08 2 27 6 13.000 3.02 330.46%
2022-05-25 2 27 6 13.000 2.39 443.93%

MNOV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


MNOV's average broker recommendation rating improved by 0 over the prior 39 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how MEDICINOVA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 43.02% of that group.
  • In terms of how MEDICINOVA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -652.56% of that group.
  • In the context of stocks in the small market cap category, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is higher than 651.58% of them.
  • MNOV has a greater average analyst price target than 212.42% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MEDICINOVA INC are MTEM, SVRA, and BPTH.

Is MNOV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6552 seconds.